'Bionanotechnology from Theory to Practice' is a short online, course providing an interdisciplinary and up-to-date overview of the rapidly developing area of bionanotechnology
Page URL: https://www.bionews.org.uk/page_96382

Hopes of sickle cell cure with genome editing

26 February 2018
Appeared in BioNews 939

Genome editing has been used to correct the mutation causing sickle cell disease in stem cells from the blood of patients.

In up to 40 percent of the blood cells, the disease-causing mutation was reversed using the CRISPR/Cas9 approach. 'The idea is to correct that particular mutation, and then stem cells that have the correction would differentiate into normal blood cells, including red blood cells,' said Professor Gang Bao at Rice University in Houston, Texas, and lead author of the study. 'Those will then be healthy blood cells.'

The team then implanted the edited human cells into the bone marrow of mice. Even 19 weeks after this transfer, the cells retained their induced correction, indicating that this is a stable change within the cells.

This raises the hope that genome edited cells could be a potential treatment for patients. However, this will need to be confirmed in future clinical trial, as Professor Bao remarked: 'We still don't know whether repairing as much as 40 percent of the cells is enough to cure a patient.'

The study, presented at the American Association for the Advancement of Science's annual conference in Austin, Texas, also found unintended changes in the genome of the corrected cells. Professor Waseem Qasim at the University College London, who was not involved in the study, told iNews that 'the question is how many cells may have other parts of their DNA change'.

Sickle cell disease affects 14,000 people in the UK and causes anaemia, infections and strokes. A single mutation in the beta-globin gene causes red blood cells to adopt an abnormal sickle shape, leading to blockages of the blood vessels, pain and potential organ damage. According to NHS Choices, current treatments for sickle cell disease involve treating the symptoms, rather than the underlying cause of the disease.

Hopes of cure for sickle cell disease
i news |  16 February 2018
Progress in pursuit of sickle cell cure
Science Daily |  16 February 2018
Rice team gains ground in CRISPR cure for sickle cell, but challenges remain
Fierce Biotech |  16 February 2018
26 July 2021 - by Michaela Chen and Jen Willows 
A knowledge gap may mean that women and girls living with sickle cell disease are not getting the best reproductive healthcare...
11 June 2018 - by Christie Whitehouse 
The US drugs regulator has put on hold an application for a clinical trial of a new genome editing based treatment for sickle cell disease...
16 April 2018 - by Shaoni Bhattacharya 
Europe's first clinical trial to use genome editing in humans has received approval to start later this year...
6 March 2017 - by Ayala Ochert 
A teenage boy in France appears to have been cured of sickle cell disease using a gene therapy. He has been free of all signs of the disease for 15 months...
14 November 2016 - by Sarah Gregory 
Researchers have had further success using the CRISPR/Cas9 genome-editing technique to repair the mutation that causes sickle-cell anaemia...
17 October 2016 - by Sarah Gregory 
Researchers have used the CRISPR/Cas9 genome-editing technique to correct the mutation that causes sickle-cell anaemia...
12 September 2016 - by Dr Nicoletta Charolidi 
A genetically engineered virus that triggers the production of an alternative form of haemoglobin has reversed the symptoms of sickle cell disease in mice...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.